The global pyrogen testing market size was US$ 1031 million in 2021. The global pyrogen testing market is forecast to grow to US$ 2512 million by 2030, registering a compound annual growth rate (CAGR) of 13.1% during the forecast period from 2022 to 2030.

Pyrogen testing is an essential practice in the manufacturing process to eliminate bacterial contaminants. The global pyrogen testing market is expected to grow significantly, owing to the growing pharmaceutical and biotechnology industries, increasing number of novel medications launches, and increasing deployment of kit-based testing. 

COVID-19 Impact Analysis

Due to the expanding incidence of infectious diseases and the rising COVID-19 pandemic, the demand for pyrogen diagnostic methodologies steadily grew. The demand for pharmaceuticals grew significantly, which raised the demand for efficient pyrogen testing to check the availability of microorganisms and eliminate them before any further harm. 

Factors Influencing the Market Growth

• Pharmaceutical, biotech, and other medication manufacturing companies use pyrogen testing methods to ensure the safe manufacture and delivery of infection-free products to the end-users. 
• Biotechnology has become a critical component of R&D activities. As a result, it is predicted to become an important element to evaluate the presence of microorganisms or metabolites in pharmaceuticals throughout their manufacturing processes.
• In addition, demand for pyrogen testing is expected to rise due to the increasing prevalence of infectious diseases. 
• The increasing number of launches and partnerships are expected to benefit the global pyrogen testing market. In addition, rising R&D expenditure will benefit the service providers during the study period. According to the information shared in the report of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical business in Europe invested over EUR 36,500 million in R&D in 2018.

Geographic Analysis

• Regionally, North America accounts for the largest pyrogen testing market due to the increasing government investment in the healthcare and pharmaceutical industry, rising healthcare expenditure, and growing pharmaceutical industry. In addition, the increasing prevalence of infectious diseases will further contribute to market growth. 
• Increasing research and development activities for introducing novel drugs will contribute to the growth of the global pyrogen testing market. 
• Asia-Pacific is forecast to witness rapid growth, owing to increasing research and development activities, rising population, and growing prevalence of chronic and infectious diseases. 
• In addition, factors like increasing government initiatives and growing healthcare expenditure will have a positive impact on the pyrogen testing market during the forecast period.

Competitors in the Market

• Associates of Cape Cod Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• GenScript Charles River Laboratories Inc.
• Ellab A/S
• Lonza Group
• WUXI Pharmatech (Cayman) Inc.
• Other prominent players

Market Segmentation

The global pyrogen testing market segmentation focuses on Product, Test, End-User, and Region,

By Product

• Kits and Reagents
• Services
• Instruments

By Test Type

• LAL Tests
  • Chromogenic Tests
  • Turbidimetric Tests
  • Gel Clot Tests
• Rabbit Pyrogen Test
• Monocyte Activation Test
• Other Test Types

By End-User

• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Other End Users

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America